Medical treatment of early breast cancer. IV: neoadjuvant treatment

Neoadjuvant Treatment of Breast Cancer.

Neoadjuvant treatment of breast cancer.

Neoadjuvant treatment of breast cancer has become established as the safe and often effective therapeutic approach of choice for larger primary and for locally advanced breast cancer. The neoadjuvant approach offers the advantages of downstaging the disease, potentially reducing the extent of surgery and in an era of individualization of therapy, testing the efficacy of therapy administered to ...

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy

Breast cancer is the most commonly diagnosed cancer in women. The latest world cancer statistics calculated by the International Agency for Research on Cancer (IARC) revealed that 1,677,000 women were diagnosed with breast cancer in 2012 and 577,000 died. The TNM classification of malignant tumor (TNM) is the most commonly used staging system for breast cancer. Breast cancer is a group of very ...

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment

1359-6349/$ see front matter Copyright 2013 ECCO the European CanCer Organisation. All rights reserved. http://dx.doi.org/10.1016/j.ejcsup.2013.07.029 * Corresponding author: Address: Breast Unit, Champalimaud Cancer Center, Av. De Brası́lia – Doca de Pedrouços, 1400-0 Portugal. Tel.: +351 (210) 480 004; fax: +351 (210) 480 298. E-mail address: [email protected] (F. Cardoso)....

Bevacizumab in neoadjuvant treatment for breast cancer.

To the Editor: The results of two studies, by von Minckwitz et al. (GeparQuinto [GBG44] trial; ClinicalTrials.gov number, NCT00567554)1 and Bear et al. (National Surgical Adjuvant Breast and Bowel Project [NSABP] B-40 trial, NCT00408408)2 (Jan. 26 issue), indicate an additional value of bevacizumab in neoadjuvant chemotherapy in patients with breast cancer. However, previous clinical studies ha...